Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct;53(4):261-269.
doi: 10.1053/j.ro.2018.08.006. Epub 2018 Aug 30.

Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ

Affiliations
Review

Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ

Nita Amornsiripanitch et al. Semin Roentgenol. 2018 Oct.

Abstract

Ductal carcinoma in situ (DCIS) of the breast is a pre-invasive breast malignancy with controversial clinical relevance and management. These lesions have increased in incidence with breast cancer screening programs and are associated with increasingly recognized clinical issues of overdiagnosis and overtreatment. This article discusses the imaging presentation of these lesions with emphasis on advances in breast MRI and its role in the management of DCIS.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

Nita Amornsiripanitch, MD

Conflict of interest: None

Diana L. Lam, MD

Conflict of interest: None

Habib Rahbar, MD

Conflict of interest: None

Figures

Figure. 1 –
Figure. 1 –
Traditional Pathologic Classification of DCIS. This includes 5 types (comedo, solid, cribriform, papillary, and micropapillary) based on architectural pattern.
Figure. 2 –
Figure. 2 –
Van Nuys Pathologic Classification. This system stratifies DCIS into two major groups – non-high and high nuclear grade, with the non-high grade divided based based on the presense of comedonecrosis. (color image)
Figure 3.
Figure 3.
Different morphologies of DCIS presenting as calcifications. Group of punctate (a) and group of amorphous (b) calcifications. Biopsy revealed low grade DCIS. Group of coarse heterogeneous (c) and pleomorphic (d) calcifications. Biopsy revealed high grade DCIS.
Figure 4.
Figure 4.
Segmental fine pleomorphic and fine linear branching calcifications. Biopsy revealed high grade DCIS. Fine linear and fine linear-branching calcifications are often seen in high nuclear grade lesions with comedonecrosis.
Figure 5.
Figure 5.
Sonographic appearances of DCIS. Oval, hypoechoic mass with circumscribed margins with no specific posterior acoustic features (a). Biopsy revealed intermediate grade DCIS. Irregular mass with indistinct margins and echogenic foci consistent with calcifications (b). Biopsy revealed DCIS with microinvasion. Dilated ducts with debris and echogenic foci consistent with calcifications in a 39 year old women with suspicious nipple discharge (c). Biopsy revealed high grade DCIS.
Figure 6.
Figure 6.
MRI appearances of DCIS. Axial T1-weighted fat-suppressed subtraction image (a) shows segmental non-mass enhancement with clumped internal enhancement. Pathology confirmed extensive high grade DCIS. Axial post-contrast T1 fat suppressed MRI image (b) shows an irregular mass with spiculated margins with a biopsy marker clip within the mass (arrow). Pathology confirmed high grade DCIS. Axial maximum intensity projection (c) shows a focus of enhancement (arrow) in a patient who had a breast MRI for recently diagnosed contralateral breast cancer. This was biopsied under MRI guidance and shown to represent low grade DCIS.

Similar articles

Cited by

References

    1. Yamada T, Mori N, Watanabe M, et al. Radiologic-pathologic correlation of ductal carcinoma in situ. Radiographics. 2010;30(5):1183–1198. - PubMed
    1. Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22–24, 2009. Journal of the National Cancer Institute. 2010;102(3):161–169. - PubMed
    1. Sumner WE 3rd, Koniaris LG, Snell SE, et al. Results of 23,810 cases of ductal carcinoma-in-situ. Annals of surgical oncology. 2007;14(5):1638–1643. - PubMed
    1. Esserman L, Yau C. Rethinking the Standard for Ductal Carcinoma In Situ Treatment. JAMA oncology. 2015. - PubMed
    1. Solin LJ. Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: the search continues. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012;30(6):577–579. - PubMed

MeSH terms